ELTP ELITE PHARMACEUTICALS INC
FollowCommon Stock (common), issuer CIK 1053369
1 manager (1 13F filer) reported a position in ELTP shares at 2026-06-30, 1,000 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 1
- 13F filers
- 1
- New
- 0
- Added
- 1
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 1,000
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Dash Barry Hdirector | 2026-10-09 | +100,000 P | $0.2598 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| KELLEHER FINANCIAL ADVISORS | 1,000 | $365 | <0.01% | +500 | 13F-HRTimeline |
Events
LaRocca John reported holdings of ELTP shares in a Form 3 filed 2026-11-06. 0001732197-26-000004
Accepted , ingestedDash Barry H bought 100,000 ELTP shares on 2026-10-09, Form 4 filed 2026-10-19. 0001493152-26-047486
Accepted , ingested